Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pitfalls in the immunophenotyping of leukaemia and leukaemic lymphomas: survey of 9 years of quality control in The Netherlands. Dutch Cooperative Study Group on Immunophenotyping of Haematological Malignancies (SIHON).
Kluin-Nelemans JC, van Wering ER, van'T Veer MB, van der Schoot CE, Adriaansen HJ, van der Burgh FJ, Gratama JW. Kluin-Nelemans JC, et al. Among authors: van der schoot ce, van t veer mb, van wering er, van der burgh fj. Br J Haematol. 1996 Dec;95(4):692-9. doi: 10.1046/j.1365-2141.1996.d01-1962.x. Br J Haematol. 1996. PMID: 8982046
Quality assessment of immunological marker analysis and the immunological diagnosis in leukaemia and lymphoma: a multi-centre study. Dutch Cooperative Study Group on Immunophenotyping of Leukaemias and Lymphomas (SIHON).
van't Veer MB, Kluin-Nelemans JC, van der Schoot CE, van Putten WL, Adriaansen HJ, van Wering ER. van't Veer MB, et al. Among authors: van putten wl, van der schoot ce, van wering er. Br J Haematol. 1992 Apr;80(4):458-65. doi: 10.1111/j.1365-2141.1992.tb04558.x. Br J Haematol. 1992. PMID: 1581230
SIHONSCORE: a scoring system for external quality control of leukaemia/lymphoma immunophenotyping measuring all analytical phases of laboratory performance.
Kluin-Nelemans J, Van Wering E, Van Der Schoot C, Adriaansen H, Van'T Veer M, Van Dongen J, Gratama J; Dutch Co-operative Study Group on Immunophenotyping of Haematological Malignancies (SIHON). Kluin-Nelemans J, et al. Br J Haematol. 2001 Feb;112(2):337-43. doi: 10.1046/j.1365-2141.2001.02500.x. Br J Haematol. 2001. PMID: 11167826 Free article.
PCR-positivity in harvested bone marrow predicts relapse after transplantation with autologous purged bone marrow in children in second remission of precursor B-cell acute leukaemia.
Vervoordeldonk SF, Merle PA, Behrendt H, Steenbergen EJ, van den Berg H, van Wering ER, von dem Borne AE, van der Schoot CE, van Leeuwen EF, Slaper-Cortenbach IC. Vervoordeldonk SF, et al. Among authors: van den berg h, van der schoot ce, van wering er, van leeuwen ef. Br J Haematol. 1997 Feb;96(2):395-402. doi: 10.1046/j.1365-2141.1997.d01-2018.x. Br J Haematol. 1997. PMID: 9029032 Free article.
The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies in children with acute lymphoblastic leukaemia.
de Haas V, Breunis WB, Dee R, Verhagen OJ, Kroes W, van Wering ER, van Dongen JJ, van den Berg H, van der Schoot CE. de Haas V, et al. Among authors: van dongen jj, van den berg h, van der schoot ce, van wering er. Br J Haematol. 2002 Jan;116(1):87-93. doi: 10.1046/j.1365-2141.2002.03228.x. Br J Haematol. 2002. PMID: 11841400 Free article.
Childhood leukaemia in The Netherlands, 1973-1986: temporary variation of the incidence of acute lymphocytic leukaemia in young children.
Coebergh JW, van der Does-van den Berg A, van Wering ER, van Steensel-Moll HA, Valkenburg HA, van't Veer MB, Schmitz PI, van Zanen GE. Coebergh JW, et al. Among authors: van zanen ge, van steensel moll ha, van der does van den berg a, van t veer mb, van wering er. Br J Cancer. 1989 Jan;59(1):100-5. doi: 10.1038/bjc.1989.20. Br J Cancer. 1989. PMID: 2788005 Free PMC article.
Three-color flowcytometric analysis of mature and immature hematological malignancies. A guideline of the Dutch Foundation for Immunophenotyping of Hematological Malignancies (SIHON).
van Wering ER, van Lochem EG, Leenders M, van der Sluijs-Gelling AJ, Wind H, Gratama JW, Kraan J, Preijers FW. van Wering ER, et al. Among authors: van der sluijs gelling aj, van lochem eg. J Biol Regul Homeost Agents. 2004 Jul-Dec;18(3-4):313-26. J Biol Regul Homeost Agents. 2004. PMID: 15786698
Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR.
van der Velden VH, Willemse MJ, van der Schoot CE, Hählen K, van Wering ER, van Dongen JJ. van der Velden VH, et al. Among authors: van dongen jj, van der schoot ce, van wering er. Leukemia. 2002 May;16(5):928-36. doi: 10.1038/sj.leu.2402475. Leukemia. 2002. PMID: 11986956
Immunological typing of acute lymphoblastic leukaemia.
van der Reijden HJ, van Wering ER, van de Rijn JM, Melief CJ, van 't Veer MB, Behrendt H, von dem Borne AE. van der Reijden HJ, et al. Among authors: van de rijn jm, van t veer mb, van wering er. Scand J Haematol. 1983 Apr;30(4):356-66. doi: 10.1111/j.1600-0609.1983.tb01507.x. Scand J Haematol. 1983. PMID: 6574590
Is there a relationship between in vitro drug resistance and level of minimal residual disease as detected by polymerase chain reaction at the end of induction therapy in childhood acute lymphoblastic leukaemia?
De Haas V, Kaspers GJ, Oosten L, Bresters D, Pieters R, Van Der Velden VH, Van Wering ER, Van Den Berg H, Van Der Schoot CE. De Haas V, et al. Among authors: van der velden vh, van den berg h, van der schoot ce, van wering er. Br J Haematol. 2002 Sep;118(4):1190-1. doi: 10.1046/j.1365-2141.2002.36211.x. Br J Haematol. 2002. PMID: 12199807 Free article. No abstract available.
182 results